565 related articles for article (PubMed ID: 15068900)
61. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain.
Bergsagel PL; Smith AM; Szczepek A; Mant MJ; Belch AR; Pilarski LM
Blood; 1995 Jan; 85(2):436-47. PubMed ID: 7529064
[TBL] [Abstract][Full Text] [Related]
62. Involvement of peripheral blood cells in multiple myeloma: chromosome changes are the rule within circulating plasma cells but not within B lymphocytes.
Zandecki M; Bernardi F; Genevieve F; Laï JL; Preudhomme C; Flactif M; Cosson A; Bauters F; Facon T
Leukemia; 1997 Jul; 11(7):1034-9. PubMed ID: 9204987
[TBL] [Abstract][Full Text] [Related]
63. A subpopulation of malignant CD34+CD138+B7-H1+ plasma cells is present in multiple myeloma patients.
Kuranda K; Berthon C; Dupont C; Wolowiec D; Leleu X; Polakowska R; Jouy N; Quesnel B
Exp Hematol; 2010 Feb; 38(2):124-31. PubMed ID: 19948206
[TBL] [Abstract][Full Text] [Related]
64. Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells.
Gazitt Y; Reading CC; Hoffman R; Wickrema A; Vesole DH; Jagannath S; Condino J; Lee B; Barlogie B; Tricot G
Blood; 1995 Jul; 86(1):381-9. PubMed ID: 7540887
[TBL] [Abstract][Full Text] [Related]
65. Tracking the follicular lymphoma cells in flow cytometry: characterisation of a new useful antibody combination.
Detry G; Drénou B; Ferrant A; Theate I; Michaux L; Scheiff JM; Latinne D; Leveugle P; Mazzon AM; Deneys V
Eur J Haematol; 2004 Nov; 73(5):325-31. PubMed ID: 15458511
[TBL] [Abstract][Full Text] [Related]
66. Production of human B cells from CD34+CD38- T- B- progenitors in organ culture by sequential cytokine stimulation.
DeLuca D; Basye JL; Schumacher MJ; Lebsack TW
Dev Comp Immunol; 2006; 30(11):1084-98. PubMed ID: 16581123
[TBL] [Abstract][Full Text] [Related]
67. Inability of a monoclonal anti-light chain antibody to detect clonal plasma cells in a patient with multiple myeloma by multicolor flow cytometry.
van Velzen JF; van den Blink D; Bloem AC
Cytometry B Clin Cytom; 2013; 84(1):30-2. PubMed ID: 23019187
[TBL] [Abstract][Full Text] [Related]
68. Plasma cells induce apoptosis of pre-B cells by interacting with bone marrow stromal cells.
Tsujimoto T; Lisukov IA; Huang N; Mahmoud MS; Kawano MM
Blood; 1996 Apr; 87(8):3375-83. PubMed ID: 8605355
[TBL] [Abstract][Full Text] [Related]
69. Maturation-associated immunophenotypic abnormalities in bone marrow B-lymphocytes in myelodysplastic syndromes.
Ribeiro E; Matarraz Sudón S; de Santiago M; Lima CS; Metze K; Giralt M; Saad ST; de Matos AO; Lorand-Metze I
Leuk Res; 2006 Jan; 30(1):9-16. PubMed ID: 16005514
[TBL] [Abstract][Full Text] [Related]
70. Phenotypic heterogeneity of B cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kampalath B; Barcos MP; Stewart C
Am J Clin Pathol; 2003 Jun; 119(6):824-32. PubMed ID: 12817430
[TBL] [Abstract][Full Text] [Related]
71. [Immunophenotyping of leukemic cells in the diagnosis of hairy cell leukemia].
Gotić M; Kraguljac N; RolovićZ ; Radosević N; Bosković D
Srp Arh Celok Lek; 2000; 128(5-6):157-64. PubMed ID: 11089415
[TBL] [Abstract][Full Text] [Related]
72. The incidence of DNA aneuploidy in multiple myeloma does not correlate with stage of disease.
Nowak R; Oelschlägel U; Range U; Mölle M; Ehninger G
Am J Clin Pathol; 1998 Feb; 109(2):226-32. PubMed ID: 9583896
[TBL] [Abstract][Full Text] [Related]
73. Phenotypic analysis of plasma cells in bone marrow using flow cytometry in AL amyloidosis.
Matsuda M; Gono T; Shimojima Y; Hoshii Y; Ikeda S
Amyloid; 2003 Jun; 10(2):110-6. PubMed ID: 12964418
[TBL] [Abstract][Full Text] [Related]
74. Antigenic transformation in plasma cell dyscrasia.
Cruse JM; Lewis RE; Webb RN; Sanders CM; Tillman BF; Beason K; Lam J; Koehler J
Exp Mol Pathol; 2006 Oct; 81(2):157-61. PubMed ID: 16908019
[TBL] [Abstract][Full Text] [Related]
75. [Detection of myeloma cells in peripheral blood using multi-parameter flow cytometry: monitoring residual disease].
Klabusay M; Doubek M; Adam Z; Hájek R; Krivanová A
Cas Lek Cesk; 2000 Jul; 139(14):432-6. PubMed ID: 11048405
[TBL] [Abstract][Full Text] [Related]
76. Plasma cell antigens in human multiple myeloma.
Mackenzie MR; Paglieroni TG
J Lab Clin Med; 1977 May; 89(5):1009-17. PubMed ID: 67161
[TBL] [Abstract][Full Text] [Related]
77. [Importance of determining the propidium-iodide index of plasmacytes in multiple myeloma. I. Relation to selected laboratory indicators of the disease].
Scudla V; Ordeltová M; Spidlová A; Bacovský J; Kurasová J; Vránová M
Vnitr Lek; 1999 Jun; 45(6):331-5. PubMed ID: 11045167
[TBL] [Abstract][Full Text] [Related]
78. [Study of anti-myeloma activity of interleukin-2 activated bone marrow in vitro].
Liu W; Chen SL; Liu JW; Li X; Xia CQ; Qi M
Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):205-8. PubMed ID: 15949260
[TBL] [Abstract][Full Text] [Related]
79. Karyotyping, immunophenotyping, and apoptosis analyses on human hematopoietic precursor cells derived from umbilical cord blood following long-term ex vivo expansion.
Tian H; Huang S; Gong F; Tian L; Chen Z
Cancer Genet Cytogenet; 2005 Feb; 157(1):33-6. PubMed ID: 15676144
[TBL] [Abstract][Full Text] [Related]
80. Diminished expression of CD19 in B-cell lymphomas.
Yang W; Agrawal N; Patel J; Edinger A; Osei E; Thut D; Powers J; Meyerson H
Cytometry B Clin Cytom; 2005 Jan; 63(1):28-35. PubMed ID: 15624204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
